Corneal Implants Market size is anticipated to surpass USD 580 million by 2030, according to a new research report by Global Market Insights Inc.
Aging people are relatively more susceptible to several ophthalmological concerns, such as macula deterioration, cataracts, glaucoma, etc., than younger people. These eye conditions often create difficulty in performing day-to-day chores and may even cause blindness when left untreated, creating favorable scenarios for the corneal implants industry.
Integration of advanced technologies to increase the adoption of artificial corneal implants
Corneal implants market from artificial cornea segment amassed over 0.5% busniess share in 2021. Due to the increasing technological advancements, such as the introduction of 3D printing and soft polymers in artificial cornea implants, the segment is set to witness lucrative growth through 2030. Companies participating in the market have been focusing on developing innovative artificial corneas to bridge the gap between required corneal implants and available human donors. In addition, the ongoing surge in sight-restoring procedures will support the market expansion.
Browse key industry insights spread across 162 pages with 233 market data tables & 18 figures & charts from the report, “Corneal Implants Market Size By Tissue (Human Donor, Artificial Cornea), By Transplant (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty, Penetrating Keratoplasty), By Condition (Fungal Keratitis, Fuchs Dystrophy, Keratoconus), By End-use (Hospitals, Eye Clinics, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
Numerous inherent advantages to drive product demand in endothelial lamellar keratoplasty procedures
Corneal implants market from the endothelial lamellar keratoplasty segment exceeded USD 120 million in 2021 and is projected to drive sizeable revenues by 2030. Endothelial lamellar keratoplasty is an alternative corneal transplant procedure that involves removing the abnormal inner lining of the cornea, also known as the endothelium, and replacing it with a donor cornea through a limbal scleral incision. The procedure does not interfere with the recipient's corneal surface, thus, is anticipated to gain significant traction over the coming years.
Non-availability of effective diagnosis and treatment to aid the industry forecasts
Corneal implants market from fungal keratitis segment to exhibit an over 7% CAGR between 2022 and 2030. This is credited to the surging incidences of fungal infections and the lack of proper and effective diagnosis and treatment. Fungal Keratitis is among the leading cause of ocular morbidity in developing economies. This has propelled the demand for adequate healthcare services and corneal implants, accelerating business landscape.
Availability of cutting-edge tools and equipment to increase eye clinics’ revenue share
The eye clinic end-user segment held over 14.5% market share in 2021 and is predicted to record a noticeable valuation by 2030. Eye clinics usually have the access to advanced eye care equipment and diagnostic tools, making them a preferred treatment choice among individuals. The rapid development in several ophthalmologic diseases among the elderly and adult populace and the availability of streamlined routine vision screening and follow-up visits across these establishments will increase the segment share.
Increasing health spending to push product demand across the Asia Pacific
Asia Pacific corneal implants market is likely to exhibit over 7.5% CAGR between 2022 and 2030. The rising awareness about corneal implants in the region, coupled with the continuous improvements in the existing healthcare infrastructure, will support the industry outlook across the Asia Pacific. Additionally, the increasing healthcare expenditure and the availability of technologically advanced and innovative eye care solutions will benefit regional progress.
Acquisitions to remain a prominent growth strategy
Notable players in the corneal implants industry are AJL Ophthalmic SA (Intacs), Alabama Eye Bank, Alcon Inc., Aurolab, CorNeat Vision Ltd., CorneaGen, DIPOTEX, Florida Lions Eye Bank, Keramed, Inc., Massachusetts Eye, and Ear, Mediphacos, Microkpro Medical, and Presbia PLC. These companies have been focusing on strengthening their strategic alliances as a key growth measure.